NCT00884715View on ClinicalTrials.gov

Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions
Carcinoid Syndrome
Interventions
DRUG

Octreotide

short acting octreotide

Trial Locations (3)

52242

Iowa City

02115

Boston

01805

Burlington

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY